Skip to content
Subscriber Only

Pfizer Pauses Chantix Distribution After Finding Carcinogen

  • Company is recalling some lots of the smoking-cessation drug
  • Distribution pause is out of abundance of caution, Pfizer says
Updated on

Pfizer Inc. said it’s pausing worldwide distribution of its smoking-cessation drug Chantix after finding elevated levels of nitrosamines, a likely carcinogen, in the pills.

The drug giant is also recalling certain lots of Chantix but didn’t say how many. The distribution halt is out of an abundance of caution, pending further testing, the company said in an email.